Sandbox:Hannan: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
Line 58: | Line 58: | ||
# AML with biallelic mutations of CEBPA | # AML with biallelic mutations of CEBPA | ||
# Provisional entity: AML with mutated RUNX1 | # Provisional entity: AML with mutated RUNX1 | ||
AML with myelodysplasia-related changes | * AML with myelodysplasia-related changes | ||
* Therapy-related myeloid neoplasms | |||
Therapy-related myeloid neoplasms | * AML, NOS | ||
# AML with minimal differentiation | |||
AML, NOS | # AML without maturation | ||
# AML with maturation | |||
AML with minimal differentiation | # Acute myelomonocytic leukemia | ||
# Acute monoblastic/monocytic leukemia | |||
AML without maturation | # Pure erythroid leukemia | ||
# Acute megakaryoblastic leukemia | |||
AML with maturation | # Acute basophilic leukemia | ||
# Acute panmyelosis with myelofibrosis | |||
Acute myelomonocytic leukemia | * Myeloid sarcoma | ||
* Myeloid proliferations related to Down syndrome | |||
Acute monoblastic/monocytic leukemia | # Transient abnormal myelopoiesis (TAM) | ||
# Myeloid leukemia associated with Down syndrome | |||
Pure erythroid leukemia | |||
Acute megakaryoblastic leukemia | |||
Acute basophilic leukemia | |||
Acute panmyelosis with myelofibrosis | |||
Myeloid sarcoma | |||
Myeloid proliferations related to Down syndrome | |||
Transient abnormal myelopoiesis (TAM) | |||
Myeloid leukemia associated with Down syndrome | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Blastic plasmacytoid dendritic cell neoplasm | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Acute leukemias of ambiguous lineage | ||
* Acute undifferentiated leukemia | |||
* Mixed phenotype acute leukemia (MPAL) with t(9;22)(q34.1;q11.2);BCR-ABL1 | |||
* MPAL with t(v;11q23.3);KMT2A rearranged | |||
* MPAL, B/myeloid, NOS | |||
* MPAL, T/myeloid, NO | |||
| | | | ||
| | | |
Revision as of 12:33, 15 January 2019
Other myeloid neoplasm and acute leukemia | |||
---|---|---|---|
Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of
PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2
|
|||
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN)
|
|||
Myelodysplastic syndromes (MDS)
|
|||
Acute myeloid leukemia (AML) and related neoplasms
|
|||
Blastic plasmacytoid dendritic cell neoplasm | |||
Acute leukemias of ambiguous lineage
|
(CML), BCR-ABL1+
- prefibrotic/early stage
- overt fibrotic stage